Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SEC14L2 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA530473
Description
Recommended positive controls: U87-MG. Predicted reactivity: Mouse (93%), Rat (94%), Pig (88%), Bovine (85%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This gene encodes a cytosolic protein which belongs to a family of lipid-binding proteins including Sec14p, alpha-tocopherol transfer protein, and cellular retinol-binding protein. The encoded protein stimulates squalene monooxygenase which is a downstream enzyme in the cholesterol biosynthetic pathway. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.
Specifications
| SEC14L2 | |
| Polyclonal | |
| Unconjugated | |
| SEC14L2 | |
| 1300013M05Rik; Alpha-tocopherol-associated protein; C22orf6; KIAA1186; KIAA1658; SEC14 like lipid binding 2; SEC14L2; SEC14-like 2; SEC14-like 2 (S. cerevisiae); SEC14-like lipid binding 2; SEC14-like protein 2; SEC14-like protein 2-like; SPF; squalene transfer protein; Supernatant protein factor; TAP; TAP1; tocopherol-associated protein; tocopherol-associated protein 1 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 23541 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 0.43 mg/mL | |
| 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
| O76054 | |
| SEC14L2 | |
| Recombinant protein encompassing a sequence within the center region of human SEC14L2. The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction